Carlsmed, Inc. Common Stock

Carlsmed launched its aprevo® Technology Platform for cervical fusion surgeries, featuring AI-driven preoperative planning and 3D-printed patient-specific implants. The platform aims to improve surgical outcomes and precision in spine procedures.

Carlsmed has appointed Jenifer Kamocsay as Chief Legal Officer and Secretary, bringing over two decades of corporate legal experience from life science and technology sectors to strengthen the company's leadership team.

Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery solutions, was added to the Russell 2000 Index following its IPO in July 2025.